Lung Ultrasound to Diagnose COVID-19
COVILUS
Use of Lung Ultrasound in Patients Suspected of COVID-19 Infection in the Emergency Room
1 other identifier
observational
100
1 country
1
Brief Summary
Covid-19 (English acronym meaning coronavirus disease 2019) is an emerging infectious disease caused by a strain of coronavirus called SARS-CoV-2. The current pandemic has resulted in a significant number of admissions in the emergency room (ER) due to suspicion of COVID-19 infection. Use of lung ultrasound is standard practice to diagnose acute respiratory failure in ER. Recently, typical lung ultrasonographic characteristics of COVID-19 disease has been described. During the COVID-19 pandemic, the use of this tool could be of interest in order to allow an early, simple and reliable triage in patients with suspected COVID-19 infection admitted in ER. In addition, the visualization of early signs in specific areas could be a predictive marker of the severity of the disease. The objective of this project will be to study the association between the signs on lung ultrasound and the result of RT-PCR in patients with suspected COVID-19 infection in the ER.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 28, 2020
CompletedStudy Start
First participant enrolled
April 28, 2020
CompletedFirst Posted
Study publicly available on registry
April 29, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 28, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
July 20, 2021
CompletedJuly 21, 2021
July 1, 2021
9 months
April 28, 2020
July 20, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Lung ultrasound/biological correlation research modulating the severity of Covid-19 disease
Polymerase chain reaction tests after reverse transcription for the detection of covid-19 viral RNA will be done as biological test.
6 months
Interventions
Polymerase chain reaction tests after reverse transcription for the detection of viral Covid-19 RNA (RT-PCR)
lung ultrasound is standard practice to diagnose acute respiratory failure in Emergency room
Eligibility Criteria
Patients admitted to Emergency Room (ER) for suspicion of COVID-19 infection who has a SARS-CoV-2 RT-PCR test and for whom the emergency doctor decide to perform a lung ultrasound as part of the BLUE protocol.
You may qualify if:
- patients admitted to Emergency Room for suspicion of COVID-19 infection with has a SARS-CoV-2 RT-PCR test and for whom the emergency doctor decide to perform a lung ultrasound
You may not qualify if:
- patients \< 18 years of age or under guardianship or curators,
- pregnancy
- poor echogenicity due to the presence of an acoustic barrier (pneumothorax, subcutaneous emphysema, etc.)
- patients with a suspected or proven acute lung disease (pneumonitis, acute respiratory distress syndrome (ARDS))
- chronic interstitial lung disease
- patients who will refuse to give their consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
BAR
Amiens, 80054, France
Related Publications (1)
Bar S, Lecourtois A, Diouf M, Goldberg E, Bourbon C, Arnaud E, Domisse L, Dupont H, Gosset P. The association of lung ultrasound images with COVID-19 infection in an emergency room cohort. Anaesthesia. 2020 Dec;75(12):1620-1625. doi: 10.1111/anae.15175. Epub 2020 Jul 1.
PMID: 32520406DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Stéphane Bar, MD
CHU Amiens
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 28, 2020
First Posted
April 29, 2020
Study Start
April 28, 2020
Primary Completion
January 28, 2021
Study Completion
July 20, 2021
Last Updated
July 21, 2021
Record last verified: 2021-07
Data Sharing
- IPD Sharing
- Will not share